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Dynamic magnetic resonance angiography
of the arteries of the hand. A comparison
between an extracellular and an intravascular
contrast agent
Abstract The purpose of this study
was to compare the image quality of the
intravascular contrast agent gadofosve-
set with the extracellular contrast agent
gadoterate meglumine in time-resolved
three-dimensional magnetic resonance
(MR) angiography of the human arte-
ries of the hand. The value of cuff
compression technique for suppression
of venous enhancement for both con-
trast agents was also investigated.
Three-dimensional MR angiograms of
both hands of 11 healthy volunteers
were acquired for each contrast agent at
1.5-T, while subsystolic cuff compres-
sion was applied at one side. Quantita-
tive and qualitative evaluation were
performed and analyzed with Student’s
t-test. Visualization of vessels was su-
perior in the images acquired with
gadofosveset, especially in the late
phases. Quantitative and qualitative
evaluation showed significantly higher
values for gadofosveset. The cuff
compression at the lower arm proved
to be an effective method to enhance
arterial vessels. In conclusion the
blood pool agent gadofosveset is
superior for the dynamic imaging of
the vessels of the hand when com-
pared with the extracellular contrast
agent gadoterate meglumine. To fully
utilize the advantages of intravascular
contrast agents, venous overlay has to
be delayed or reduced, which can be
achieved effectively by subsystolic
lower arm cuff compression.
Keywords Magnetic resonance
angiography . Blood pool contrast
agents . Peripheral vascular imaging .
Cuff compression technique
Introduction/Objective
Digital subtraction angiography (DSA) is still considered
to be the “gold standard” for angiography of the arteries of
the human hand. Although invasive, it has not yet been
surpassed by magnetic resonance angiography (MRA).
This is due to the still superior contrast-to-noise ratio
(CNR) level and spatial resolution when compared with
MRA, especially in the most peripheral segments of the
vascular tree where the vessels are small. But MRA is
about to catch up and has some advantages over DSA as
well. It is minimally invasive, has no ionizing radiation
exposure, can create a three-dimensional (3D) data set and
may be combined with soft-tissue imaging for further
diagnostic workup.
Furthermore, developments inMR imaging technique and
hardware lead to a continuous improvement of temporal and
spatial resolution as well as CNR. Recently, additionally to
the established gadolinium (Gd)-based extracellular contrast
agents for generalMR imaging, intravascular contrast agents
(or blood pool agents) have been introduced clinically as
specific contrast agents for vascular MR exams. At present,
only one of these agents is clinically available, which is
gadofosveset (Vasovist, Bayer Schering Pharma, Germany).
This molecule is reversibly attached to albumin in the blood
and therefore remains intravascular for hours. Also, its
relaxivity, meaning its ability to lower the T1- and T2-time of
the adjacent tissue protons and thereby increasing its signal
in T1-weighted sequences, is higher compared with other
Gd-based contrast agents.
C. Reisinger (*) . T. Gluecker .








Contrast-enhanced MRA has been shown to be a robust
and reproducible method to visualize the vessels of the
hand, providing images of diagnostic quality [1]. However,
the low spatial and temporal resolution with a low CNR
and the impairment of arterial depiction by early venous
enhancement remain as major problems [2].
With the introduction of the subsystolic venous cuff
compression technique, a significant reduction of venous
overlay was achievable and allowed arterial imaging before
venous enhancement [3]. It also could be shown that a lower
flow rate further lowers venous overlay [4]. But to increase
the CNR, especially in the most peripheral arterial territory,
elevation of the Gd concentration and/or relaxivity up to a
certain degree is necessary. Until now, only extracellular
contrast agents have been used for the imaging of the hand
vessels. Now, with intravascular contrast agents, the restric-
tion of diffusion of gadofosveset molecules into the inter-
stitial space should lead to higher peripheral vascular Gd
concentrations. This should even be amplified by the higher
relaxivity of the molecule caused by the binding to the
albumin. A drawbackmay be increased venous enhancement
that might hamper the arterial read out. Therefore, we
hypothesized that the application of intravascular contrast
agent will increase CNR values along the complete vascular
tree of the hand and thereby may improve the arterial
depiction in comparison with extracellular contrast agents.
To our knowledge, no study has yet been published that
compares the visualization of the vessels of the hand with
extracellular and intravascular contrast agents. The purpose
of our study was to assess the use of intravascular contrast
agents in combination with subsystolic cuff compression.
Materials and methods
Both hands of 11 non-smoking healthy volunteers (seven
male; four female; mean age 27 years, age range 19–
45 years) were examined twice in an interval of 7 days with
a dynamic sequence. For a single examination eight 3D
data sets with an acquisition time of 24 s each were
obtained consecutively, with the second set starting
simultaneously with contrast agent injection. The measure-
ment before the administration of the contrast agent served
as a mask for subtraction. This resulted in seven phases (or
series) of post-contrast angiographies. In one case, the
number of averages was increased by two to achieve an
increased signal of the distal vessels, resulting an acqui-
sition time per frame of 48 s. These angiograms were not
included in the statistical evaluation.
Image acquisition
For the examination, we used a 1.5-T whole-body MR
system (Espree, Siemens Medical Solutions, Erlangen,
Germany) with a time-resolved 3D gradient-echo sequence
and following imaging parameters: 3D gradient-echo
sequences with field of view 336×252 mm; matrix size
384×271 pixels; voxel size 0.9×0.9×0.9 mm; TR/TE
4.32/1.32; flip angle 40; acquisition time per slab 24 s; 60
partitions per slab; partition thickness 0.9 mm; bandwidth
430 Hz/pixel; time of k-space center 7.9 s; zero filling;
parallel imaging mode iPAT GRAPPA; acceleration factor
2. The integrated spine coil and a flexible body coil were
used for signal detection. Venous compression was applied
at one side by inflating a standard blood pressure cuff at
mid portion of the lower arm approximately 1 min before
contrast-agent injection with a subsystolic pressure of
80 mmHg. The pressure was manually maintained during
the whole arterial image acquisition. The systemic blood
pressure was measured before imaging. The unilateral
application of compression permitted an intraindividual
comparison of venous overlay between the compressed and
non-compressed side. This method was similar to a
previously established method [3] with the exception that
this time cuff compression was at the lower arm, for this
location is easier to access in the prone position.
Contrast agent administration
Contrast agent was applied with an injection rate of 2 ml/s
and a standard concentration of 0.1 mmol Gd/kg body
weight for gadoterate meglumine (Gd-DOTA, Dotarem,
Guerbet, Aulney-sous-Bois, France) and of 0.03 mmol
Gd/kg body weight for gadofosveset (Vasovist, Bayer
Schering Pharma, Berlin, Germany), followed by a flush
of 20 ml of normal saline (0.9%). The r1 relaxivity of
the used contrast agents at 1.5 T and 37°C in blood
are 4.2 mmol−1s−1 for gadoterate meglumine and
19 mmol−1s−1 for gadofosveset [5]. Injection was delivered
into an antecubital vein of the non-compressed arm. A
power injector (Spectris, Medrad, Pittsburgh, Pa.) was used
for administration. All volunteers were examined in the
prone position with both hands in pronation above the head.
The thumbs were separated by soft cushions and slightly
fixed to avoid induction currents and motion artifacts.
For every volunteer, written informed consent was
obtained and the creatinine values were measured for
calculation of the clearance rate at least 24 h before the first
study. For estimation of the renal clearance, the Cockroft/
Gault-formula was used. A cut-off value of 60 ml/min was
chosen. Further exclusion criteria were metal implants or
foreign bodies, age below 18 or above 75 and claustro-
phobia. Volunteers were questioned after each study
regarding adverse effects and discomfort during the study.
Data evaluation
Quantitative evaluation of CNR as well as qualitative
assessment of arterial visualization and venous overlay
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were performed. For quantitative assessment of CNR
polygonal regions of interest (ROIs) were defined in the
source images in six different vascular regions as well as in
the adjacent soft tissue and outside the body. The following
arterial locations were measured: the distal radial artery, the
distal ulnar artery, the superficial palmar arterial arch, the
princeps polices artery, one common digital artery (usually
MC2/3) and at least one proper digital artery (Fig. 1a).
Noise was defined as the standard deviation (SD) of signal
intensity (SI) of a constant area outside the body.
The CNR was calculated as CNR ¼ SIvesselð
SIadjacent soft tissueÞ

noise . The mean CNR measured over
all the vessel segments was calculated and compared
between the different phases and contrast agents.
For qualitative evaluation, maximum intensity projec-
tions (MIPs) were reconstructed in the coronal plane prior
to evaluation. The vessels were divided into a proximal, an
intermediate and a distal segment, being separated by the
palmar arch and the bifurcation into the proper digital
arteries (Fig. 1b). These were evaluated independently for
both hands and different phases. Qualitative data evalua-
tion was performed by three experienced radiologists (A.L.
J., T.G., D.B.), with at least 5 years’ experience in vascular
imaging. Each reviewer was unaware of the contrast agent
used and the other reviewer’s assessment. The different
series were presented separately as MIP images and in a
randomized order. The source images where available
when needed. The arterial visualization score was rated on
a four-point scale: 0=nondiagnostic study or no arterial
filling; 1=poor data quality, diagnostic impairment;
2=suboptimal arterial signal, no diagnostic impairment;
3=good arterial signal. The venous overlay was rated on a
four-point scale: 0=no venous contamination; 1=minimal
venous contamination, no reduction of diagnostic value;
2=major venous contamination, important diagnostic
impairment; 3=nondiagnostic study. Statistical analysis
was performed using a paired Student’s t-test for both
qualitative and quantitative data. A calculated p value of
less than 0.05 was considered statistically significant.
The study protocol was approved by the local ethics
committee.
Results
All examinations have been successfully completed,
resulting in 22 angiograms of both hands. There were no
complications that led to interruption or termination of the
study. The volunteers stated some discomfort because of
the inflated cuff and lying in a prone position but none
complained about pain or paresthesia. No complications or
adverse side effects related to the contrast material were
observed.
To illustrate the intraindividual difference in arterial
enhancement between both contrast agents, the two series
of MIP reconstructed contrast-enhanced MR angiograms
of the hand on the compressed side over time are displayed
in Fig. 2, the first row being acquired with gadoterate
meglumine and the second with gadofosveset. Both
contrast agents led to sufficient enhancement of the
proximal arteries starting approximately 72 s after injec-
tion. Filling of the distal arteries is completed after 120 s.
During this time the arterial signal in the gadoterate
meglumine series already decreases and the noise is
increasing probably due to distribution in the extravas-
cular, extracellular space. Therefore, in particular the
digital arteries are displayed insufficiently. In the series
acquired with gadofosveset, the arterial depiction remains
constant over time and is only hampered by slight
venous overlay distally, starting about 144 s after contrast
agent injection.
Quantitative evaluation of arterial signal
in the different segments
The mean CNR values for all arterial vessel segments over
time are displayed in Fig. 3. Here, with both contrast agents
the CNR starts to increase similarly at about 48 s after
contrast-agent injection without cuff compression and
about 72 s after injection with cuff compression applied.
With gadoterate meglumine there is an early signal
decrease in both extremities, whereas gadofosveset shows
a late plateau phase with higher signal intensity. This
difference in CNR proved to be statistically significant
(p=0.0001 and 0.0028). On average, the highest measured
CNR value per series was 42.0 for gadofosveset and 33.7
for gadoterate meglumine, respectively.
Fig. 1 Arterial vessel segments measured for the estimation of CNR
(A–F) and segmentation for the rating of arterial visualization and
venous overlay (proximal, intermediate, distal)
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Qualitative evaluation of arterial visualization
The assessments of arterial visualization are displayed
separately for the different segments in Fig. 4a–c, from
proximal to distal artery segments. Without compression,
both contrast agents showed similar results over time with
an early rising score but a deterioration of arterial depiction
starting about 96 s after contrast injection. Still, values for
gadofosveset tend to be slightly higher. The score was
dependent on venous overlay, as major venous overlay led
to non-diagnostic arterial imaging. With cuff compression
applied, the score rises a little later (about one sequence=
24 s) but stays on longer and reaches higher values,
especially with gadofosveset. This pattern is somewhat
comparable with the CNR graph. The differences in arterial
visualization score between both contrast agents were
statistically significant for all segments and both hands (see
Table 1, mean AVS). The mean out of the highest score
given per subject and segment is higher for gadofosveset as
well (Table 1, mean highest AVS). The more distal the
evaluated arteries, the less was the score. While proximal
arteries received overall good scores (Fig. 4a), the digital
arteries received predominantly non-diagnostic scores with
the applied sequence (Fig. 4c).
Fig. 2 Maximum intensity pro-
jections of the hand of a single
volunteer with cuff compression
applied. The upper row shows
the enhancement of the vascular
tree over time when gadoterate
meglumine was injected. The
lower row shows the corre-
sponding angiograms with ga-
dofosveset as contrast agent.
While with both contrast agents
early enhancement was similar
with nice depiction of the prox-
imal arteries, the late images
obtained with gadoterate me-
glumine show increasing noise,
probably due to distribution in
the extravascular, extracellular
space. Therefore, especially the
peripheral arteries are displayed
insufficiently when compared
with the series acquired with
gadofosveset
Fig. 3 Mean CNR of all arterial segments separately for contrast
agent and compression technique. Both contrast agents show
similar vascular enhancement in early acquisitions, while during
the later phases the mean CNR was significantly higher with
gadofosveset (gray) than with gadoterate meglumine (black).
Without cuff compression (circles), the CNR increases earlier,
though equal values are reached with both agents using cuff
compression (triangles)
"?>Fig. 4 Average rating for arterial visualization, separately for each
segment (a–c). On the uncompressed side (circles), with both
contrast agents the arterial depiction increases early and drops off
again because of venous overlay and signal loss. With cuff
compression applied (triangles), depiction starts a little later but
stays on longer and reaches higher values, especially with
gadofosveset. At the intermediate and distal arteries the graphs
show a similar pattern but have a lower scale. The distal arteries
especially were rarely rated above a score of 1 or 2. This implies that
the imaging sequence used is not sufficient for diagnostic depiction
of digital arteries
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The doubling of acquisition time per frame in one
volunteer led to improved signal and delineation, especially
of the distal small arteries, showing that proper timing will
help increasing image quality (images not shown).
Assessment of cuff compression technique
The use of the lower arm cuff compression was well
tolerated in all subjects. To illustrate the impact of cuff
compression, a series of MIP reconstructed images of a
contrast-enhanced MR angiogram of both hands is
displayed in Fig. 5. Compression was applied on the
right side. The left side was without compression (non-
compressed) and major venous overlay was observed early,
compromising especially the evaluation of the distal
arteries. This example illustrates the reduction of venous
enhancement on the compressed side and the improved
image quality related to compression. Though cuff com-
pression led to a delay in arterial filling of approximately
one image acquisition phase when compared with the
uncompressed side. However, venous filling was delayed
even more, usually starting with slow filling of the digital
veins approximately 120 s after contrast agent injection.
Thus, a phase with no or only minor venous overlay of 40–
60 s resulted.
In Fig. 6, the assessment of venous overlay is displayed.
For both the compressed and the non-compressed extremity,
the score for venous enhancement increased similarly over
time when comparing both contrast agents. Without cuff-
compression applied, studies became non-diagnostic after
approximately 96 s; while with cuff compression, the rating
for venous overlay remained low until the end of the
measurements. No significant differences between both
contrast agents were found (Table 1, VCS). With cuff
compression applied, higher arterial visualization scores were
reached when using gadofosveset (Table 2). These differ-
ences were less pronounced with gadoterate meglumine.
Discussion
Imaging of the vessels of the hand may become necessary
in patients with peripheral vascular or connective tissue
disease and vascular lesions of the hand [6]. Due to its
superior spatial resolution and the long-standing experi-
ence with this method, DSA is still considered to be the
gold standard of palmar vessel depiction. However,
contrast-enhanced MRA of the hand can already provide
information approaching that of conventional angiography
[1]. Furthermore, it is a noninvasive, quick and easy
examination that produces a 3D data set of high-quality
images without exposure to ionizing radiation. It is readily
available in many institutions and can be used to obtain
additional information of soft tissue and bone involvement.
However, to make this method feasible for clinical routine
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and to ensure diagnostic results in MRA, the small digital
vessels especially have to be depicted sufficiently; thus,
adequate spatial resolution with high vessel contrast is
essential. Intravascular contrast agents were specifically
developed for contrast-enhanced MRA and promise to
facilitate fulfillment of these criteria.
As our study shows, gadofosveset as intravascular
contrast agent in fact improves first pass imaging of the
arterial tree of the hand when compared with the extracel-
lular agent gadoterate meglumine. This might be to some
part due to the higher relaxation rate of intravascular
contrast agents. The relaxivity of gadoterate meglumine at
37°C in blood is 4.2 l·mmol−1s−1 and for gadofosveset it is
19 l·mmol−1s−1, which is a factor of 4.5 more [5]. The
injected Gd concentration was “only” 3.3-times lower for
gadofosveset (0.1 vs 0.03 mmol/kg), which leads theore-
tically to a 1.36-times higher relaxivity per injection.
However, with gadofosveset a smaller bolus was injected
Table 1 Comparison of gadoterate meglumine and gadofosveset,
separated by extremity and segment (AVS arterial visualization
score, mean highest AVS the average of the highest score assigned to
a segment during the whole sequence, CNR max highest CNR value
per series). AVS and VCS were measured on the respective four-
point scales; CNRs are absolute values
Segments Gadoterate Gadofosveset Gadoterade Gadofosveset
w/o cuff w/o cuff cuff cuff
Mean AVS Proximal 0.87 1.32 p<0.0001* 1.1 1.59 p<0.0001*
Intermediate 0.52 0.8 p=0.0011* 0.64 1.02 p=0.0002*
Distal 0.13 0.24 p=0.024* 0.21 0.39 p=0.0028*
Mean highest AVS Proximal 2.6 2.9 2.6 2.9
Intermediate 1.83 2.36 1.93 2.16
Distal 0.6 0.9 0.96 1.4
CNR max All 34.9 42.6 p=0.0001* 33.7 42.0 p=0.0028
VCS All 1.41 1.42 p=0.86 0.51 0.44 p=0.11
*Significant differences
Fig. 5 These angiograms of a single volunteer were consecutively
obtained with gadofosveset as contrast agent. Cuff compression was
applied on the right side. Major venous overlay occurs early on the
non-compressed extremity compromising especially the evaluation
of the distal arteries. On the compressed side, arterial enhancement
is delayed but venous filling was diminished even more effectively
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(0.12 vs 0.2 ml/kg body weight). This in turn may lead to
an advantage for gadoterate meglumine, since increased
bolus size correlates with improved arterial depiction [4].
These differences in the injection protocol are in fact a
limitation of this study. But in direct comparison, fading of
arterial signal—probably due to distribution in the extra-
vascular, extracellular space and diffusion—could be seen
with gadoterate meglumine especially in the late phases,
while gadofosveset retains a strong signal. This is reflected
by significant differences in the qualitative as well as the
quantitative data evaluation. Interestingly, even though an
increased venous enhancement was expected for the
intravascular contrast agent, the readers’ score for venous
overlay was equivalent for both contrast agents. On the
compressed extremity overlay was rated even a little less
with gadofosveset. Probably the expected increase of
venous contrast filling is compensated for by an increase of
arterial signal intensity.
One of the advantages of blood pool agents lies in a
prolonged intravascular residence that allows extended
imaging with higher optical resolution in the steady state
phase. Though we did not further investigate this, we think
that steady state imaging is currently not feasible for the
vessels of the hand due to their small size and the overlap of
arteries and veins (as we have observed in the late phases
without compression). But sequences and algorithms for
automatic differentiation of arteries and veins are currently
under development and may change this in the future [7].
So far, venous overlay restricts arterial assessment. We
demonstrated that continuous subsystolic lower arm cuff
compression is an effective method to avoid or at least
delay venous enhancement of arterial images. The mech-
anism of cuff compression works by a reduction of
superficial vein blood flow with drainage through the
deep veins and a venous-arterial backpressure mechanism
via the capillary bed, which reduces arterial inflow velocity
towards the lower arm arteries. The subsystolic cuff
compression technique has already successfully been
used to improve MR angiographic imaging of the lower
extremity [8, 9]. It has also been utilized for the upper
extremity as well [4]. But in difference to other protocols,
in our study the cuff compression was applied at the lower
arm, as this site is easier to access in the prone position.
A different approach was developed with suprasystolic
compression to arrest blood flow in the arterial phase,
thereby being able to extend image acquisition time,
resulting in higher vessel signal and resolution [10].
Though this method requires individual bolus tracking
technique and exact timing. Our continuous subsystolic
cuff compression is easier to perform, more comfortable for
the patient and allows dynamic depiction of arterial and
subsequently venous filling. Still, there may be conditions
in which venous depiction or abnormal and early venous
filling can reveal pathologic features like venous mal-
formations or hemangiomas.
A cuff pressure of 80 mmHg, which we used in our
study, leads to a delay in arterial filling as well but is
compensated for by a longer venous-free vessel depiction
of about 40–60 s. This has to be regarded for acquisition
schemes. As a restriction to this study, only a small set of
volunteers with a mean age of 27 years was evaluated. It is
known that in patients with vascular disease and in an older
population the contrast kinetics vary significantly [11]. For
instance, patients suffering from cellulites have rapid
arteriovenous communication with a short arterial phase
and increased incidence of venous contamination [12].
Table 2 Comparison of compressed versus non-compressed ex-
tremity, separated by contrast agent and segment. For both contrast
agents, the highest AVS per sequence was reached with compres-
sion, while this difference was less pronounced with gadoterate
meglumine. AVS was measured on the four-point scale. Numbers in
parentheses state the time of maximum scoring
Segments Gadofosveset Gadofosveset Gadoterate Gadoterate
w/o cuff cuff w/o cuff cuff
Highest mean AVS Proximal 2.1 (72 s) 2.6 (144 s) p=0.026* 1.9 (72 s) 2.0 (96 s) p=0.027*
Intermediate 1.4 (48 s) 1.8 (120 s) p=0.052 1.2 (72 s) 1.4 (96 s) p=0.14
Distal 0.5 (72 s) 0.9 (120 s) p=0.025* 0.4 (72 s) 0.8 (96 s) p=0.084
*Significant differences
Fig. 6 Mean score for venous overlay. Venous enhancement is
significantly higher without compression applied (circles). Though
there is no significant difference between the two contrast agents
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Therefore, further studies with higher temporal resolution
focusing on patients with different vascular diseases may
be necessary to optimize the imaging protocol. Further-
more techniques for vasodilatation, like warming-up the
extremities with warm water or tempered cushions, may be
useful but should be evaluated for the impact on the
temporal change of arterial enhancement and venous filling
first. The local application of vasodilating drugs as used in
DSA is obviously not feasible with MRA, which may be
the only inherent disadvantage of this non-invasive image
acquisition.
The imaging sequence of our study showed to be
insufficient for the diagnostic evaluation of the distal
vessels of the hand. For improved depiction of the distal
arteries the spatial resolution has to be increased. This may
be accomplished by decreasing the field of view to one
hand or a special region of interest, while using a dedicated
hand or wrist coil. Additionally, when using cuff compres-
sion acquisition time can be extended. In one example, we
successfully extended the acquisition time to 48 s,
receiving one phase of complete arterial enhancement
without venous overlay on the compressed side. This way,
diagnostic images with 0.5-mm isotropic resolution or less
should be possible.
In conclusion, the use of the blood pool agent gadofosveset
can improve the dynamic imaging of the vessels of the hand
when compared with the extracellular gadoterate meglu-
mine. But to fully utilize the advantages of intravascular
contrast agents, venous overlay has to be delayed or reduced,
which can effectively be achieved by lower-arm subsystolic
cuff compression. However, especially in the distal arteries,
image quality does not presently meet diagnostic standards
with either the blood pool or extracellular contrast agent
when using this protocol.
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